VPA Verified Effective for Sterilizing Bioabsorbable Medical Devices
The medical device industry is increasingly relying upon the use of bioabsorbable implants, and that trend will continue to grow. In fact, the bioabsorbable stent market alone is expected to reach $2.4B by 2021, up from $400M in 2016, according to a 2016 MarketsandMarkets report. Traditional sterilization methods, however, have typically posed significant problems for implants like bioabsorbable stents and related FDA Class II and Class III medical devices.
Read our white paper which explains how the innovative usage of vaporized peracetic acid (VPA) provides a safe, reliable, and versatile method for sterilizing bioabsorable implants. It describes the thorough testing method used to verify that bioabsorbable polymers are fully compatible with the VPA process, and it shows the specific results of these tests using Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy and other measurements. For instance, sterilization methods that operate at high temperatures, such as steam autoclave, can damage, degrade, or even melt the polymer materials used in these implants. Likewise, chemical processes such as ethylene oxide (EO) sterilization can leave behind carcinogenic residuals. VPA offers an alternative sterilization solution that is both safe and effective for these bioabsorbable devices.
Download White Paper